D'Amico, Adele
 Distribuzione geografica
Continente #
NA - Nord America 2.733
EU - Europa 2.339
AS - Asia 2.105
SA - Sud America 474
AF - Africa 64
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.729
Nazione #
US - Stati Uniti d'America 2.627
SG - Singapore 1.053
DE - Germania 763
CN - Cina 520
BR - Brasile 381
SE - Svezia 368
IT - Italia 297
IE - Irlanda 179
FR - Francia 168
GB - Regno Unito 133
UA - Ucraina 108
IN - India 96
VN - Vietnam 87
ID - Indonesia 78
FI - Finlandia 68
RU - Federazione Russa 59
CA - Canada 49
AR - Argentina 43
PL - Polonia 43
HK - Hong Kong 38
JP - Giappone 35
NL - Olanda 35
BD - Bangladesh 32
MX - Messico 31
TR - Turchia 31
KR - Corea 23
ES - Italia 20
ZA - Sudafrica 20
BE - Belgio 19
IQ - Iraq 19
AT - Austria 16
IR - Iran 15
EC - Ecuador 14
CH - Svizzera 13
MA - Marocco 12
PK - Pakistan 12
CO - Colombia 11
CZ - Repubblica Ceca 11
PA - Panama 10
UZ - Uzbekistan 10
LT - Lituania 9
VE - Venezuela 9
IL - Israele 8
CI - Costa d'Avorio 7
EG - Egitto 7
AU - Australia 6
PE - Perù 6
PY - Paraguay 5
TN - Tunisia 5
AM - Armenia 4
CL - Cile 4
CR - Costa Rica 4
DZ - Algeria 4
KG - Kirghizistan 4
KZ - Kazakistan 4
RO - Romania 4
SA - Arabia Saudita 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
DK - Danimarca 3
HU - Ungheria 3
KE - Kenya 3
LB - Libano 3
LV - Lettonia 3
MY - Malesia 3
NG - Nigeria 3
NP - Nepal 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
GE - Georgia 2
JM - Giamaica 2
LK - Sri Lanka 2
NI - Nicaragua 2
TH - Thailandia 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
ME - Montenegro 1
MG - Madagascar 1
MO - Macao, regione amministrativa speciale della Cina 1
Totale 7.722
Città #
Singapore 536
Chandler 392
Ashburn 340
Dublin 165
New York 157
Frankfurt am Main 130
Beijing 108
Los Angeles 88
Jakarta 74
San Mateo 72
Hefei 70
Jacksonville 61
Milan 59
Rome 58
Houston 56
Boston 55
Munich 50
Wilmington 50
Dallas 48
Moscow 43
Nanjing 42
Nürnberg 40
São Paulo 40
Hong Kong 38
Marseille 37
Chicago 36
Bremen 30
Helsinki 30
Princeton 30
Ho Chi Minh City 29
Woodbridge 29
Ann Arbor 28
Tokyo 28
Warsaw 27
Buffalo 26
Dearborn 26
Lawrence 23
Santa Clara 22
Seoul 22
Denver 20
Hanoi 20
London 20
Nuremberg 19
Orem 19
Seattle 19
Brooklyn 18
Fairfield 18
Chennai 17
Kent 17
Johannesburg 16
Lancaster 16
Boardman 15
Changsha 15
Hebei 15
Izmir 15
Nanchang 15
Poplar 15
Redwood City 15
Rio de Janeiro 15
San Francisco 15
Brussels 13
Cattolica 13
Inverigo 13
Montreal 13
The Dalles 13
Toronto 13
Amsterdam 12
Paris 12
Buenos Aires 11
Mexico City 11
Stockholm 11
Washington 11
Augusta 10
Düsseldorf 10
Norwalk 10
Turku 10
Charlotte 9
Detroit 9
Leawood 9
Phoenix 9
Pune 9
San Jose 9
Tianjin 9
Zhengzhou 9
Belo Horizonte 8
Cambridge 8
Columbus 8
Kish 8
Lauterbourg 8
Palermo 8
Shenyang 8
Tashkent 8
University Park 8
Abidjan 7
Atlanta 7
Jinan 7
Manchester 7
Menlo Park 7
Mountain View 7
Secaucus 7
Totale 3.928
Nome #
Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy 293
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 278
Spinal muscular atrophy 234
Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design. 165
SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCR. 164
Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study. 153
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 152
Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience 137
SMA-miRs (MiR-181a- 5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples 135
Different trajectories in upper limb and gross motor function in spinal muscular atrophy 134
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 133
SMA-miRs (MiR-181a- 5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples 133
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy 132
Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study 131
Cardiac Function in Types II and III Spinal Muscular Atrophy: Should We Change Standars of Care? 131
24 month longitudinal data in ambulant boys with duchenne muscular dystrophy 123
Type I SMA “new natural history”: long-term data in nusinersen-treated patients 122
Clinical-genetic features and peculiar muscle histopathology in infantile DNM1L-related mitochondrial epileptic encephalopathy 119
Expanding the clinical-pathological and genetic spectrum of RYR1-related congenital myopathies with cores and minicores: an Italian population study 119
Timed Rise from Floor as a Predictor of Disease Progression in Duchenne Muscular Dystrophy: An Observational Study 117
Type I Spinal Muscular Atrophy patients treated with nusinersen: 4 year follow-up of motor, respiratory and bulbar function 116
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype 116
Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophy 116
Sometimes they come back: New and old spinal muscular atrophy adults in the era of nusinersen 115
Prevalence of Duchenne muscular dystrophy in Italy: a nationwide survey 110
Age, corticosteroid treatment and site of mutations affect motor functional changes in young boys with Duchenne Muscular Dystrophy 106
An Italian family with autosomal recessive inclusion-body myopathy and mutations in the GNE gene 106
Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials 105
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 105
Respiratory Trajectories in Type 2 and 3 Spinal Muscular Atrophy in the iSMAC Cohort Study 105
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 104
The empowerment of translational research: lessons from laminopathies 103
Revised north star ambulatory assessment for young boys with Duchenne muscular dystrophy 102
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA Participants 101
Fetal acetylcholine receptor inactivation syndrome and maternal myasthenia gravis: a case report 100
Copy Number Variants Account for a Tiny Fraction of Undiagnosed Myopathic Patients. 99
Outcome of fetuses with congenital cytomegalovirus infection: a systematic review and meta-analysis 99
Body mass index in type 2 spinal muscular atrophy: a longitudinal study 99
Role of prenatal magnetic resonance imaging in fetuses with isolated anomalies of corpus callosum: multinational study 98
Histological effects of givinostat in boys with Duchenne muscular dystrophy 97
Longitudinal natural history in young boys with Duchenne muscular dystrophy 97
Effect of mexiletine on transitory depression of compound motor action potential in recessive myotonia congenita 96
Genetic modifiers of upper limb function in Duchenne muscular dystrophy 94
Healthy design and urban planning strategies, actions, and policy to achieve salutogenic cities 94
Clinical Variability in Spinal Muscular Atrophy Type III. 94
MRI in sarcoglycanopathies: a large international cohort study 93
Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy 92
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 91
Development of an academic disease registry for spinal muscular atrophy 90
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 88
An observational study of functional abilities in infants, children, and adults with type 1 SMA 87
Registries versus tertiary care centers: How do we measure standards of care in Duchenne muscular dystrophy? 86
New Mutations in NEB Gene Discovered by Targeted Next-Generation Sequencing in Nemaline Myopathy Italian Patients 84
“Art, Colors, and Emotions” Treatment (ACE-t): A Pilot Study on the Efficacy of an Art-Based Intervention for People With Alzheimer’s Disease 82
null 81
Gain and loss of abilities in type II SMA: A 12-month natural history study 81
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 80
Long term follow-up of scoliosis progression in type II SMA patients 77
Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression. 76
The genetic basis of undiagnosed muscular dystrophies and myopathies 76
Mosaic caveolin-3 expression in acquired rippling muscle disease without evidence of myasthenia gravis or acetylcholine receptor autoantibodies 75
MRI in sarcoglycanopathies: A large international cohort study 70
Sometimes they come back: New and old spinal muscular atrophy adults in the era of nusinersen 68
Early Neurodevelopmental Findings Predict School Age Cognitive Abilities in Duchenne Muscular Dystrophy: A Longitudinal Study 66
Novel Splicing Mutation in MTM1 Leading to Two Abnormal Transcripts Causes Severe Myotubular Myopathy 64
null 64
Italian recommendations for diagnosis and management of congenital myasthenic syndromes 64
Pathogenic role of mtDNA duplications in mitochondrial diseases associated with mtDNA deletions. 62
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 56
Muscle imaging in patients with tubular aggregate myopathy caused by mutations in STIM1 53
A Recurrent Pathogenic Variant of INPP5K Underlies Autosomal Recessive Congenital Muscular Dystrophy With Cataracts and Intellectual Disability: Evidence for a Founder Effect in Southern Italy 52
Developmental lag of visuospatial attention in Duchenne muscular dystrophy 48
Mitochondrial Neurogastrointestinal Encephalomyopathy Presenting as Anorexia Nervosa 46
Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation 39
Insulin-like growth factor I in inclusion-body myositis and human muscle cultures 34
1st Italian SMA Family Association Consensus Meeting: Management and recommendations for respiratory involvement in spinal muscular atrophy (SMA) types I-III, Rome, Italy, 30-31 January 2015 11
1st Italian SMA Family Association Consensus Meeting: Management and recommendations for respiratory involvement in spinal muscular atrophy (SMA) types I-III, Rome, Italy, 30-31 January 2015 10
Totale 7.828
Categoria #
all - tutte 35.759
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.759


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021185 0 0 0 0 0 19 43 8 36 14 63 2
2021/2022526 32 17 9 46 27 26 9 77 37 39 109 98
2022/20231.218 124 152 79 197 84 146 80 97 133 36 62 28
2023/2024820 39 191 43 58 39 159 51 40 22 24 67 87
2024/20251.468 36 47 111 60 139 58 77 77 187 114 299 263
2025/20262.485 526 125 250 533 795 256 0 0 0 0 0 0
Totale 7.828